跳至主要内容
临床试验/NCT06831539
NCT06831539招募中1 期

Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery

Centre hospitalier de l'Université de Montréal (CHUM)1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年12月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
To evaluate the impact of bowel preparation on the gut microbiota at 1 week after bowel preparation.

研究概览

简要总结

The main objective is to evaluate the impact of intestinal preparation on the composition, diversity and metabolome of the intestinal microbiota.

详细描述

Based on the limited literature that PEG does not significantly impact the microbiome, certain investigators ascertain that administration of PEG without any subsequent FMT would represents the gold-standard control group. On the other hand, other investigators raised their concern that perturbation of the microbiome with PEG without subsequent replacement with FMT might negatively impact immune checkpoint inhibitor efficacy. Therefore, there is an unmet need to conduct a study using the metagenomic shotgun sequencing to precisely understand the impact of bowel preparation on gut microbiome composition and on the dynamics of recovery of the gut microbiome after bowel preparation to better design microbiome-centered trials.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteer participant cohort:
  • > 18 years of age
  • The participant has provided documented informed consent for the participation and to complete PEG bowel preparation and return collected stool samples.

排除标准

  • Significant gastric retention
  • Suspected or established mechanical bowel obstruction
  • Inflammatory or infectious gastrointestinal condition
  • Neurologic or cognitive impairment that prevents safe swallowing
  • Recent history (<1 year) of cancer that still requires ongoing treatment
  • Recent use of antibiotics 1 month prior to participation in the trial
  • History of cardiac disease
  • History of active renal dysfunction
  • Presence of any absolute contraindication to PEG bowel preparation according to manufacturer labeling

研究组 & 干预措施

Healthy volunteer participant cohort

Experimental

For healthy volunteer participants, PEG bowel preparation will be administered and participants will collect stool samples before and after PEG at specified timepoints.

干预措施: PEGLyte bowel preparation (Drug)

结局指标

主要结局

To evaluate the impact of bowel preparation on the gut microbiota at 1 week after bowel preparation.

时间窗: At week 1

Study of the gut microbiota composition at 1 week after bowel preparation.

次要结局

  • Gut microbiome composition, diversity, and gut metabolome profile at 1 month and 3 months after bowel preparation(At 1 month and 3 months)

研究者

发起方
Centre hospitalier de l'Université de Montréal (CHUM)
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验